Skip to main content

that starts at the very source

Built on a field-proven HVT+IBD technology backbone, VAXXITEK® vaccines give birds an essential foundation for optimal response to external threats throughout their lifespan.

The VAXXITEK® Portfolio

Discover our products to protect your flock effectively.

  • vaxxitek ibd


    THE INNOVATIVE LEADER. Just one shot at the hatchery provides 2-in-1 protection against IBD and MD in broiler, layer, and breeder chickens.

    Read More
  • Vaxxitek ND


    DESIGNED FOR YOU. Strong immune foundation and optimized protection against MD, IBD, and ND.

    Read More
  • vaxxitek ilt


    The Power to Protect: Uniquely and Conveniently. A solid immune foundation with protection against ILT, MD, and IBD in one shot.

    Read More
Chickens 2

VAXXITEK® Protects your flock

VAXXITEK® is brought to you by Boehringer Ingelheim, the trusted leader in infectious bursal disease (IBD) vector vaccine technology. This history of leadership is reflected in the company’s introduction of turkey herpesvirus (HVT) vector vaccines using one virus to control multiple diseases, providing game-changing solutions for the poultry industry.

  • Moves vaccination from field to hatchery, reducing chick-handling stress as well as labor time and operating costs
  • Provides protection against some of the most serious and economically threatening diseases in poultry health, including IBD, MD, ND, and ILT
  • Establishes an immune foundation for your flock

Protection against serious disease threats

With VAXXITEK®, you can count on trusted protection. Launched in 2006, VAXXITEK® HVT+ IBD was the first HVT+IBD vector vaccine on the market, making it the historical leader in IBD vaccination.



Vaxxitek® protects your flock

  • Chicken


    Protected and Counting

  • Planet


    Use VAXXITEK® Vaccines

  • Book

    Portfolio Offers Protection Against


  • Vaxxitek Amps


    Support VAXXITEK® Vaccines

The VAXXITEK® protects against serious disease threats

VAXXITEK® vaccines are the first line of vector vaccines built on an HVT+IBD technology platform. This backbone delivers effective protection and lifelong immune support with the added flexibility of ND and ILT protection when needed.

Infectious Bursal Disease (IBD)

  • One of the most common viral infections in chickens, mainly affecting chickens up to 6 weeks old whose bursas are still under development
  • Can cause debilitating clinical signs and an underlying immunosuppression that leads to poor growth and performance, with significant economic impact on the poultry industry
  • IBD virus is highly contagious and, once established, can be very difficult to eradicate in farm and production environments

Marek’s Disease (MD)

  • A herpesvirus-induced lymphoproliferative disease of chickens
  • Virus causes transformation and proliferation of T-cells
  • Clinical presentations may include visceral or subcutaneous tumors, neuronal paralysis, and blindness due to lymphocyte invasion of the iris

Newcastle Disease (ND)

  • Highly contagious respiratory disease that primarily infects chickens, but also turkeys and other avian species, such as wild and cage birds
  • Numerous serotypes and strains exist, ranging from low to high virulence
  • Associated with a variety of respiratory and neurological symptoms, poor egg production, and varying degrees of mortality

Infectious Laryngotracheitis (ILT)

An acute viral respiratory disease caused by Gallid herpesvirus type I (GaHV-1)

Causes severe respiratory clinical signs and lesions in the trachea

Can lead to major economic losses worldwide

See VAXXITEK® portfolio in action


to see how Vaxxitek can help your flock

References: 1. Rautenschlein S, Simon B, Jung A, Pöppel M, Prandini F, Lemiere S. Protective efficacy of VAXXITEK HVT+IBD in commercial layers and broilers against challenge with very virulent infectious bursal disease virus. XVI Congress of the World Veterinary Poultry Association; 2009: Marrakesh, Morocco. 2. Le Gros F-X, Dancer A, Iacomini C, et al. Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers. Vaccine. 2009;27:592–596. 3. Data on file. Boehringer Ingelheim Animal Health. 4. Morton DB. Vaccines and animal welfare. Rev Sci Tech. 2007;26:157–163. 5. Lemiere S, Rojo F, Fernandez R, et al. Benefits of the herpesvirus of turkey vector vaccine of infectious bursal disease in control of immuno-depression in broilers and decrease of use of antibiotic medication. Abstract presented at the XVIII Congress of the World Veterinary Poultry Association; 2013: Nantes, France. 6. Hoelzer K, Bielke L, Blake DP, et al. Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions. Vet Res. 2018;49:70. 7. Atienza JC, Nagera AJ, Martinez PO, et al. Evaluation of a herpesvirus of turkey vector vaccine inducing protection against infectious bursal and Marek’s diseases (VAXXITEK® HVT+IBD) under Philippines field conditions. Abstract presented at the XXIII World’s Poultry Congress; 29 June 29–July 4, 2008; Queensland, Australia. 8. Rautenschlein S, Lemiere S, Simon B, Prandini F. A comparison of the effects of the humoral and cell-mediated immunity between an HVT-IBD vector vaccine and an IBDV-immune complex vaccine after in ovo vaccination of commercial broilers. Abstract presented at the XVII Congress of the World Veterinary Poultry Association Congress; 2011: Cancun, Mexico. 9. Tang SF, He SJ, Li WM, Lemiere S. Field experience of vaccination in day-old broiler chickens with a herpesvirus turkey-infectious bursal disease (HVT-IBD) vector vaccine in different systems of chicken production across China. Poster presentation. Abstract presented at the XVII Congress of the World Veterinary Poultry Association; 2011: Cancun, Mexico. 10. Zhou X, Wang D, Xiong J, Zhang P, Li Y, She R. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein. Vaccine. 2010;28:3990–3996.


This website is intended to be an international resource for general purpose information. Accordingly, the content provided is international in nature and is for veterinarians only.

Please be aware that country-specific information may be more relevant to you, which in some cases may differ from the general information provided on this website.